Theraclone In the News

Media professionals who wish to learn more about Theraclone’s technology and areas of research and development, please contact us at:

media@theraclone-sciences.com
206.805.1600

Access recent media coverage of Theraclone via the links below.

Flu Vaccines Hit a Wall
Technology Review, October 13, 2009

Antibodies found that prevent HIV from causing severe AIDS
Los Angeles Times, September 4, 2009

Biotech-assisted antibody discovery may lead to AIDS vaccine
Fierce Biotech, September 4, 2009

Discovery Of New HIV Antibodies Opens Door To Effective AIDS Vaccine
Medical News Today, September 4, 2009

Study finds potential way to make an AIDS vaccine
Reuters, September 3, 2009

Powerful HIV-Blocking Antibodies Raise New Hopes for Vaccine
Bloomberg, September 3, 2009

Discoveries Brighten Search for AIDS Vaccine
HealthDay News, September 3, 2009

Antibodies 'may aid HIV jab hunt'
BBC News, September 3, 2009

A fluttering in the breeze
The Economist, September 3, 2009

Unique antibodies may be the key for AIDS vaccine
The Globe and Mail News, September 3, 2009

Antibodies for HIV, Long Dismissed, Show Signs of Comeback at Seattle’s Theraclone
Xconomy.com, April 7, 2009

Biotech firm attracts $29 million in 2nd funding round
Seattle Times, March 17, 2007

$29 million gives biotech Spaltudaq funds to grow
Seattle Post-Intelligencer, March 17, 2007

New biotech Spaltudaq has different take on cancer fight
Seattle Post-Intelligencer, January 24, 2005

Startup targets tumor weapons
Seattle Times, January 24, 2005